| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.6M | -27.9% |
| Cost of Revenue | $10.2M | -28.7% |
| R&D Expense | $688K | -39.3% |
| SG&A Expense | $7.6M | -26.2% |
| Operating Income | -$11.6M | +17.1% |
| Pre-tax Income | -$13.1M | +15.0% |
| Income Tax | -$28K | -193.3% |
| Net Income | -$5.1M | +66.7% |
| EPS (Basic) | -$52.87 | +69.6% |
| EPS (Diluted) | -$52.87 | +70.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | +61.7% |
| Accounts Receivable | $3.6M | +111.7% |
| Inventory | $4.3M | +114.7% |
| Current Assets | $17.6M | +53.0% |
| Total Assets | $27.0M | +24.7% |
| Current Liabilities | $7.3M | -27.0% |
| Long-term Debt | $708K | -89.4% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +46.2% |
| Capital Expenditures | $61K | -56.7% |
| Investing Cash Flow | -$505K | -263.3% |
| Financing Cash Flow | $11.0M | -35.0% |
| Free Cash Flow | -$7.8M | +46.3% |
| $8.5M |
| -51.7% |
| Stockholders' Equity | $15.8M | +292.8% |